ASH 2017: Role of Autologous Stem Cell Transplant (ASCT)
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discuss the role of autologous stem cell transplant (ASCT) for multiple myeloma during the IMWG Conference Series filmed at ASH 2017 in Atlanta, Georgia.
We thank our supporters of this program:
Abbvie, AMGEN, Bristol-Myers Squibb Celgene Corporation, Janssen Oncology, Takeda Oncology
Previous Post
ASH 2017: Frontline Options
Next Post
ASH 17: Maintenance Recommendations